Albion Financial Group UT Sells 1,282 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Albion Financial Group UT reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 128,698 shares of the financial services provider’s stock after selling 1,282 shares during the quarter. iShares Biotechnology ETF makes up 1.2% of Albion Financial Group UT’s portfolio, making the stock its 26th largest holding. Albion Financial Group UT owned approximately 0.26% of iShares Biotechnology ETF worth $17,015,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Modus Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $41,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth about $59,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $136.10 on Wednesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a 50-day moving average price of $136.15 and a 200 day moving average price of $141.84.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.